Methylprednisolone in the treatment of post-COVID-19 Interstitial Lung Disease (STERCOV-ILD)
A. YUKSEL (Ankara, Turkey), D. Karadogan (Rize, Turkey), N. Hürsoy (Rize, Turkey), G. Telatar (Rize, Turkey), N. Köse (Bilecik, Turkey), F. Marim (Kütahya, Turkey), I. Kaya (Kütahya, Turkey), A. Er (Usak, Turkey), M. Erçelik (Afyonkarahisar, Turkey), D. Polat (Mersin, Turkey), M. Yumrukuz (Balikesir, Turkey), C. I?lgar (Ankara, Turkey), Ö. Gültekin (Erzurum, Turkey), S. Çakmakçi (Denizli, Turkey), B. Yilmaz Kara (Rize, Turkey), N. Özçelik (Rize, Turkey), I. Selimoglu (Rize, Turkey), K. Uyar Er (Rize, Turkey), A. Kotan (Rize, Turkey), H. Keskin (Rize, Turkey), M. Akgün (Erzurum, Turkey)
Source: International Congress 2022 – Interstitial lung diseases diagnosis in the COVID-19 era: new tools for new challenges
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. YUKSEL (Ankara, Turkey), D. Karadogan (Rize, Turkey), N. Hürsoy (Rize, Turkey), G. Telatar (Rize, Turkey), N. Köse (Bilecik, Turkey), F. Marim (Kütahya, Turkey), I. Kaya (Kütahya, Turkey), A. Er (Usak, Turkey), M. Erçelik (Afyonkarahisar, Turkey), D. Polat (Mersin, Turkey), M. Yumrukuz (Balikesir, Turkey), C. I?lgar (Ankara, Turkey), Ö. Gültekin (Erzurum, Turkey), S. Çakmakçi (Denizli, Turkey), B. Yilmaz Kara (Rize, Turkey), N. Özçelik (Rize, Turkey), I. Selimoglu (Rize, Turkey), K. Uyar Er (Rize, Turkey), A. Kotan (Rize, Turkey), H. Keskin (Rize, Turkey), M. Akgün (Erzurum, Turkey). Methylprednisolone in the treatment of post-COVID-19 Interstitial Lung Disease (STERCOV-ILD). 447
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|